In this week’s issue of The Savvy Diabetic: 1st Rapid-Acting Biosimilar Insulin Approved UVa AI-Powered Insulin Delivery Susvimo for Diabetic Macular Edema Oral Insulin Prevention Trial (PDF) GLP-1 Agonists Increased …
GLP1
-
General Health
-
Diabetes Complications
The use of perioperative GLP-1 RA reduces the risk of complications in diabetic patients
by News Sourceby News Source(Health Day News)-In the case of diabetes patients who have undergone surgical treatment, the active percherative peptide-1 receptor agonist (GLP-1 RA) prescription is re-hospitalized after the risk adjustment, wound detachment, …
-
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), significantly improving access to diabetes treatment. Glucagon-like peptide-1 (GLP-1) receptor agonists are designed to …
-
Top Line Use of GLP-1 drugs such as semaglutide for weight loss has doubled in the past decade, but uptake among people with type 2 diabetes has declined, according to …
-
Type 2
GLP-1 reduces risk of 10 types of cancer compared with insulin in type 2 diabetes patients
by News Sourceby News SourceAdd a topic to an email alert Get emails when new articles are published Enter your email address to receive emails when new articles are published. …
-
health Source: RFstudio/Pexels There has been some controversy over the use of a class of drugs known as GLP-1 agonists to treat obesity. GLP-1 agonists, also known as GLP-1, are …
-
Glucagon-like peptide 1 (GLP-1) receptor agonists are the latest blockbuster drugs thanks to their powerful ability to help patients lose weight. But shortages are expected to last until the end …